These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

334 related items for PubMed ID: 20497129

  • 21. Interleukin-1 expression in inflammatory myopathies: evidence of marked immunoreactivity in sarcoid granulomas and muscle fibres showing ischaemic and regenerative changes.
    Authier FJ, Mhiri C, Chazaud B, Christov C, Cherin P, Barlovatz-Meimon G, Gherardi RK.
    Neuropathol Appl Neurobiol; 1997 Apr; 23(2):132-40. PubMed ID: 9160898
    [Abstract] [Full Text] [Related]

  • 22. Inflammatory myopathies: evaluation and management.
    Greenberg SA.
    Semin Neurol; 2008 Apr; 28(2):241-9. PubMed ID: 18351525
    [Abstract] [Full Text] [Related]

  • 23. Major histocompatibility complex class I and II expression in idiopathic inflammatory myopathy.
    Das L, Blumbergs PC, Manavis J, Limaye VS.
    Appl Immunohistochem Mol Morphol; 2013 Dec; 21(6):539-42. PubMed ID: 23343957
    [Abstract] [Full Text] [Related]

  • 24. Polymyositis and dermatomyositis in children: an epidemiologic and clinical comparative analysis.
    Hanissian AS, Masi AT, Pitner SE, Cape CC, Medsger TA.
    J Rheumatol; 1982 Dec; 9(3):390-4. PubMed ID: 7120234
    [Abstract] [Full Text] [Related]

  • 25. Pathogenic aspects of dermatomyositis, polymyositis and overlap myositis.
    Gherardi RK.
    Presse Med; 2011 Apr; 40(4 Pt 2):e209-18. PubMed ID: 21376512
    [Abstract] [Full Text] [Related]

  • 26. Comparative utility of LC3, p62 and TDP-43 immunohistochemistry in differentiation of inclusion body myositis from polymyositis and related inflammatory myopathies.
    Hiniker A, Daniels BH, Lee HS, Margeta M.
    Acta Neuropathol Commun; 2013 Jul 01; 1():29. PubMed ID: 24252466
    [Abstract] [Full Text] [Related]

  • 27. Alpha-chemokine receptors CXCR1-3 and their ligands in idiopathic inflammatory myopathies.
    De Paepe B, De Keyzer K, Martin JJ, De Bleecker JL.
    Acta Neuropathol; 2005 Jun 01; 109(6):576-82. PubMed ID: 15937690
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Multiplex immunoassay analysis of cytokines in idiopathic inflammatory myopathy.
    Baird GS, Montine TJ.
    Arch Pathol Lab Med; 2008 Feb 01; 132(2):232-8. PubMed ID: 18251582
    [Abstract] [Full Text] [Related]

  • 31. Expression of calcium-binding proteins MRP8 and MRP14 in inflammatory muscle diseases.
    Seeliger S, Vogl T, Engels IH, Schröder JM, Sorg C, Sunderkötter C, Roth J.
    Am J Pathol; 2003 Sep 01; 163(3):947-56. PubMed ID: 12937135
    [Abstract] [Full Text] [Related]

  • 32. A high incidence of disease flares in an open pilot study of infliximab in patients with refractory inflammatory myopathies.
    Dastmalchi M, Grundtman C, Alexanderson H, Mavragani CP, Einarsdottir H, Helmers SB, Elvin K, Crow MK, Nennesmo I, Lundberg IE.
    Ann Rheum Dis; 2008 Dec 01; 67(12):1670-7. PubMed ID: 18272672
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Dermatomyositis. Diagnosis and evaluation of dermatomyositis, polymyositis, and inclusion-body myositis.
    Krajnc I.
    Adv Exp Med Biol; 1999 Dec 01; 455():181-6. PubMed ID: 10599341
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Polymyositis and dermatomyositis (first of two parts).
    Bohan A, Peter JB.
    N Engl J Med; 1975 Feb 13; 292(7):344-7. PubMed ID: 1090839
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.